AbbVie Inc.
AbbVie Inc. (ABBV) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ABBV · as of Sep 30, 2024
Ownership Breakdown
3,604
Institutional Holders
▲ 131 vs Q2
$251.24B
Total Inst. Value
▲ $34.46B vs Q2
1.77B
Shares Outstanding
freeFloat 99.88%
1.27B
13F Shares Held
▲ 4.54M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ABBV largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 171.65M | 9.70% | 9.70% | $33.90T | Nov 13, 2024 | ▲ 988.3K |
BLACKROCK, INC. pharmaceutical preparations | 135.97M | 7.69% | 7.69% | $26.85T | Nov 13, 2024 | NEW |
STATE STREET CORP pharmaceutical preparations | 79.07M | 4.47% | 4.47% | $15.61T | Nov 14, 2024 | ▲ 1.27M |
JPMORGAN CHASE & CO pharmaceutical preparations | 52.31M | 2.96% | 2.96% | $10.33T | Dec 26, 2024 | ▼ 1.25M |
MORGAN STANLEY pharmaceutical preparations | 38.72M | 2.19% | 2.19% | $7.65T | May 14, 2025 | ▲ 1.47M |
CAPITAL INTERNATIONAL INVESTORS pharmaceutical preparations | 36.79M | 2.08% | 2.08% | $7.26T | Nov 13, 2024 | ▼ 1.81M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 36.16M | 2.04% | 2.04% | $7.12T | Nov 12, 2024 | ▼ 520.7K |
CAPITAL RESEARCH GLOBAL INVESTORS pharmaceutical preparations | 33.21M | 1.88% | 1.88% | $6.56T | Nov 13, 2024 | ▲ 20.2K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC pharmaceutical preparations | 23.84M | 1.35% | 1.35% | $4.71T | Nov 12, 2024 | ▼ 1.14M |
NORGES BANK pharmaceutical preparations | 22.98M | 1.30% | 1.30% | $4.54T | Nov 12, 2025 | ▲ 496.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
26
Increased
+21.51M shares1
New Positions
first time holders23
Decreased
−13.58M shares0
Sold Out
fully exitedNet shares change (top 50)
+7.93M
+21.51M / −13.58M
Net new holders
+4
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ABBV insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
49
Buy transactions
18
Sell transactions
2.72
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
FALK THOMAS J director | May 8, 2026 | Award | 1,118 | — | — | 2.3K | Form 4 ↗ |
WADDELL FREDERICK H director | May 8, 2026 | Award | 1,118 | — | — | 30.1K | Form 4 ↗ |
Roberts Rebecca B director | May 8, 2026 | Award | 1,118 | — | — | 14.8K | Form 4 ↗ |
RAPP EDWARD J director | May 8, 2026 | Award | 1,118 | — | — | 46.0K | Form 4 ↗ |
Quaggin Susan E director | May 8, 2026 | Award | 1,118 | — | — | 3.6K | Form 4 ↗ |
MEYER MELODY B director | May 8, 2026 | Award | 1,118 | — | — | 17.6K | Form 4 ↗ |
Hart Brett J director | May 8, 2026 | Award | 1,118 | — | — | 20.6K | Form 4 ↗ |
FREYMAN THOMAS C director | May 8, 2026 | Award | 1,118 | — | — | 127.9K | Form 4 ↗ |
Davis Jennifer L. director | May 8, 2026 | Award | 1,118 | — | — | 3.6K | Form 4 ↗ |
BURNSIDE WILLIAM H.L. director | May 8, 2026 | Award | 1,118 | — | — | 28.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
AbbVie Inc. (ABBV) is primarily owned by institutional investors, who hold approximately 71.9% of total shares outstanding. Company insiders own approximately 0.12%, while retail and public investors account for the remaining 28.01%.
The largest institutional shareholder of AbbVie Inc. is VANGUARD GROUP INC, holding approximately 171.65 million shares — equal to 9.70% of outstanding shares — as of September 30, 2024.
A total of 3,604 institutional investors currently hold ABBV stock, with a combined institutional value of approximately $251.24 billion as of the most recent 13F filing period.
Frequently asked questions
ABBV ownershipAbbVie Inc. (ABBV) is primarily owned by institutional investors, who hold approximately 71.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.70% stake. Company insiders hold 0.12%. Data sourced from SEC Form 13F as of September 30, 2024.